ELI LILLY & Co·4

Feb 12, 4:19 PM ET

Ricks David A 4

4 · ELI LILLY & Co · Filed Feb 12, 2025

Insider Transaction Report

Form 4
Period: 2025-02-10
Ricks David A
DirectorPresident, Chair, and CEO
Transactions
  • Award

    Common Stock

    2025-02-10$868.88/sh+55,131.56$47,902,710539,613.167 total
  • Award

    Restricted Stock Unit

    2025-02-10+31,93231,932 total
    From: 2026-02-01Exp: 2026-02-01Common Stock (31,932 underlying)
Holdings
  • Common Stock

    (indirect: By David A. Ricks SLAT)
    68,656
  • Common Stock

    (indirect: By Trust)
    300
  • Common Stock

    (indirect: By David A. Ricks 2022 GRAT)
    59,457
  • Common Stock

    (indirect: By 401(k))
    7,264.97
Footnotes (2)
  • [F1]The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Documents

1 file
  • 4
    wk-form4_1739395137.xmlPrimary

    FORM 4